The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C

被引:88
作者
Barber, LD
Percival, L
Valiante, NM
Chen, L
Lee, C
Gumperz, JE
Phillips, JH
Lanier, LL
Bigge, JC
Parekh, RB
Parham, P
机构
[1] STANFORD UNIV,SCH MED,DEPT BIOL STRUCT,STANFORD,CA 94305
[2] STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305
[3] STANFORD UNIV,SCH MED,DEPT CHEM,STANFORD,CA 94305
[4] PERKIN ELMER CORP,APPL BIOSYST DIV,FOSTER CITY,CA
[5] DNAX RES INST MOL & CELLULAR BIOL INC,DEPT HUMAN IMMUNOL,PALO ALTO,CA 94304
[6] OXFORD GLYCOSYST LTD,ABINGDON OX14 1RG,OXON,ENGLAND
关键词
D O I
10.1084/jem.184.2.735
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The vast majority of new human HLA class I alleles are formed by conversions between existing alleles of the same locus. A notable exception to this rule is HLA-B*4601 formed by replacement of residues 66-76 of the alpha 1 helix of B*1501 by the homologous segment of Cw*0102. This inter-locus recombination, which brings together characteristic elements of HLA-B and HLA-C structure, is shown here to influence function dramatically. Naturally processed peptides bound by B*4601 are distinct from those of its parental allotypes B*1501 and Cw*0102 and dominated by three high abundance peptides. Such increased peptide selectivity by B*4601 is unique among HLA-A,B,C allotypes. For other aspects of function, presence of the small segment of HLA-C-derived sequence in an otherwise HLA-B framework converts B*4601 to an HLA-C-like molecule. Alloreactive cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and cellular glycosidases all recognize B*4601 as though it were an HLA-C allotype. These unusual properties are those of an allotype which has frequencies as high as 20% in south east Asian populations and is associated which predisposition to autoimmune diseases and nasopharyngeal carcinoma.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 28 条
[1]  
Barber LD, 1996, J IMMUNOL, V156, P3275
[2]   OVERLAP IN THE REPERTOIRES OF PEPTIDES BOUND IN-VIVO BY A GROUP OF RELATED CLASS-I HLA-B ALLOTYPES [J].
BARBER, LD ;
GILLECECASTRO, B ;
PERCIVAL, L ;
LI, XB ;
CLAYBERGER, C ;
PARHAM, P .
CURRENT BIOLOGY, 1995, 5 (02) :179-190
[3]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[4]  
BAUR MP, 1984, HISTOCOMPATIBILITY T
[5]   AMINO-ACID SUBSTITUTIONS CAN INFLUENCE THE NATURAL-KILLER (NK)-MEDIATED RECOGNITION OF HLA-C MOLECULES - POLE OF SERINE-77 AND LYSINE-80 IN THE TARGET-CELL PROTECTION FROM LYSIS MEDIATED BY GROUP-2 OR GROUP-1 NK CLONES [J].
BIASSONI, R ;
FALCO, M ;
CAMBIAGGI, A ;
COSTA, P ;
VERDIANI, S ;
PENDE, D ;
CONTE, R ;
DIDONATO, C ;
PARHAM, P ;
MORETTA, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :605-609
[6]   HLA AND NASOPHARYNGEAL CARCINOMA IN CHINESE - A FURTHER STUDY [J].
CHAN, SH ;
DAY, NE ;
KUNARATNAM, N ;
CHIA, KB ;
SIMONS, MJ .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (02) :171-176
[7]   HLA AND THYROTOXICOSIS (GRAVES-DISEASE) IN CHINESE [J].
CHAN, SH ;
YEO, PPB ;
LUI, KF ;
WEE, GB ;
WOO, KT ;
LIM, P ;
CHEAH, JS .
TISSUE ANTIGENS, 1978, 12 (02) :109-114
[8]   A CHALLENGE TO THE INSTRUCTIVE MODEL OF POSITIVE SELECTION [J].
CHAN, SH ;
BENOIST, C ;
MATHIS, D .
IMMUNOLOGICAL REVIEWS, 1993, 135 :119-131
[9]   POLYMORPHISM OF T-CELL RECEPTOR GENES IN NASOPHARYNGEAL CARCINOMA [J].
CHEN, Y ;
CHAN, SH .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) :830-833
[10]   HLA-C IS THE INHIBITORY LIGAND THAT DETERMINES DOMINANT RESISTANCE TO LYSIS BY NK1-SPECIFIC AND NK2-SPECIFIC NATURAL-KILLER-CELLS [J].
COLONNA, M ;
BORSELLINO, G ;
FALCO, M ;
FERRARA, GB ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :12000-12004